Abstract
Due to their role in controlling translation, microRNAs emerged as novel therapeutic targets to modulate post-stroke outcomes. We previously reported that miR-21 is the most abundantly induced microRNA in the brain of rodents subjected to preconditioning-induced cerebral ischemic tolerance. We currently show that intracerebral administration of miR-21 mimic decreased the infarct volume and promoted better motor function recovery in adult male and female C57BL/6 mice subjected to transient middle cerebral artery occlusion. The miR-21 mimic treatment is also efficacious in aged mice of both sexes subjected to focal ischemia. Mechanistically, miR-21 mimic treatment decreased the post-ischemic levels of several pro-apoptotic and pro-inflammatory RNAs, which might be responsible for the observed neuroprotection. We further observed post-ischemic neuroprotection in adult mice administered with miR-21 mimic intravenously. Overall, the results of this study implicate miR-21 as a promising candidate for therapeutic translation after stroke.
Similar content being viewed by others
Data Availability
Authors will provide all data when requested following the procedures and rules governed by the University of Wisconsin and William S. Middleton VA Hospital Research Center of Madison, WI.
References
Chandran R, Mehta SL, Vemuganti R. Non-coding RNAs and neuroprotection after acute CNS injuries. Neurochem Int. 2017;111:12–22.
Kim T, Mehta SL, Morris-Blanco KC, Chokkalla AK, Chelluboina B, Lopez M, et al. The microRNA miR-7a-5p ameliorates ischemic brain damage by repressing alpha-synuclein. Sci Signal. 2018;11(560):eaat4285.
Li G, Morris-Blanco KC, Lopez MS, Yang T, Zhao H, Vemuganti R, et al. Impact of microRNAs on ischemic stroke: from pre- to post-disease. Prog Neurobiol. 2018;163–164:59–78.
Ma F, Sun P, Zhang X, Hamblin MH, Yin KJ. Endothelium-targeted deletion of the miR-15a/16–1 cluster ameliorates blood-brain barrier dysfunction in ischemic stroke. Sci Signal. 2020;13(626):eaay5686.
Sohrabji F, Selvamani A. Sex differences in miRNA as therapies for ischemic stroke. Neurochem Int. 2019;127:56–63.
Dharap A, Bowen K, Place R, Li LC, Vemuganti R. Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab. 2009;29(4):675–87.
Selvamani A, Sathyan P, Miranda RC, Sohrabji F. An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model. PLoS One. 2012;7(2):e32662.
Siegel C, Li J, Liu F, Benashski SE, McCullough LD. miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proc Natl Acad Sci USA. 2011;108(28):11662–7.
Yin KJ, Deng Z, Huang H, Hamblin M, Xie C, Zhang J, et al. miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis. 2010;38(1):17–26.
Yang Z, Zhong L, Zhong S, Xian R, Yuan B. miR-203 protects microglia mediated brain injury by regulating inflammatory responses via feedback to MyD88 in ischemia. Mol Immunol. 2015;65(2):293–301.
Yu H, Wu M, Zhao P, Huang Y, Wang W, Yin W. Neuroprotective effects of viral overexpression of microRNA-22 in rat and cell models of cerebral ischemia-reperfusion injury. J Cell Biochem. 2015;116(2):233–41.
Dirnagl U, Becker K, Meisel A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol. 2009;8(4):398–412.
Li S, Hafeez A, Noorulla F, Geng X, Shao G, Ren C, et al. Preconditioning in neuroprotection: from hypoxia to ischemia. Prog Neurobiol. 2017;157:79–91.
Lopez MS, Dempsey RJ, Vemuganti R. Resveratrol preconditioning induces cerebral ischemic tolerance but has minimal effect on cerebral microRNA profiles. J Cereb Blood Flow Metab. 2016;36(9):1644–50.
Saugstad JA. Non-coding RNAs in stroke and neuroprotection. Front Neurol. 2015;6:50.
Dharap A, Vemuganti R. Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways. J Neurochem. 2010;113(6):1685–91.
Biggar KK, Storey KB. Identification and expression of microRNA in the brain of hibernating bats. Myotis lucifugus Gene. 2014;544(1):67–74.
Gu GL, Xu XL, Sun XT, Zhang J, Guo CF, Wang CS, et al. Cardioprotective effect of microRNA-21 in murine myocardial infarction. Cardiovasc Ther. 2015;33(3):109–17.
Ji W, Jiao J, Cheng C, Shao J. MicroRNA-21 in the Pathogenesis of traumatic brain injury. Neurochem Res. 2018;43(10):1863–8.
Liu B, Wei H, Lan M, Jia N, Liu J, Zhang M. MicroRNA-21 mediates the protective effects of salidroside against hypoxia/reoxygenation-induced myocardial oxidative stress and inflammatory response. Exp Ther Med. 2020;19(3):1655–64.
Xu X, Kriegel AJ, Jiao X, Liu H, Bai X, Olson J, et al. miR-21 in ischemia/reperfusion injury: a double-edged sword? Physiol Genomics. 2014;46(21):789–97.
Chokkalla AK, Mehta SL, Kim T, Chelluboina B, Kim J, Vemuganti R. Transient focal ischemia significantly alters the m(6)A epitranscriptomic tagging of RNAs in the brain. Stroke. 2019;50(10):2912–21.
Morris-Blanco KC, Kim T, Lopez MS, Bertogliat MJ, Chelluboina B, Vemuganti R. Induction of DNA hydroxymethylation protects the brain after stroke. Stroke. 2019;50(9):2513–21.
Kim T, Chelluboina B, Chokkalla AK, Vemuganti R. Age and sex differences in the pathophysiology of acute CNS injury. Neurochem Int. 2019;127:22–8.
Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab. 1990;10(2):290–3.
Mehta SL, Dempsey RJ, Vemuganti R. Role of circular RNAs in brain development and CNS diseases. Prog Neurobiol. 2020;186:101746.
Lusardi TA, Murphy SJ, Phillips JI, Chen Y, Davis CM, Young JM, et al. MicroRNA responses to focal cerebral ischemia in male and female mouse brain. Front Mol Neurosci. 2014;7:11.
Lv B, Cheng X, Sharp FR, Ander BP, Liu DZ. MicroRNA-122 mimic improves stroke outcomes and indirectly inhibits NOS2 after middle cerebral artery occlusion in rats. Front Neurosci. 2018;12:767.
Panta A, Pandey S, Duncan IN, Duhamel S, Sohrabji F. Mir363-3p attenuates post-stroke depressive-like behaviors in middle-aged female rats. Brain Behav Immun. 2019;78:31–40.
Stary CM, Xu L, Li L, Sun X, Ouyang YB, Xiong X, et al. Inhibition of miR-181a protects female mice from transient focal cerebral ischemia by targeting astrocyte estrogen receptor-alpha. Mol Cell Neurosci. 2017;82:118–25.
Sun P, Zhang K, Hassan SH, Zhang X, Tang X, Pu H, et al. Endothelium-targeted deletion of microRNA-15a/16-1 promotes poststroke angiogenesis and improves long-term neurological recovery. Circ Res. 2020;126(8):1040–57.
Verma R, Ritzel RM, Harris NM, Lee J, Kim T, Pandi G, et al. Inhibition of miR-141-3p ameliorates the negative effects of poststroke social isolation in aged mice. Stroke. 2018;49(7):1701–7.
Bautista-Sanchez D, Arriaga-Canon C, Pedroza-Torres A, De La Rosa-Velazquez IA, Gonzalez-Barrios R, Contreras-Espinosa L, et al. The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics. Mol Ther Nucleic Acids. 2020;20:409–20.
Bhalala OG, Pan L, Sahni V, McGuire TL, Gruner K, Tourtellotte WG, et al. microRNA-21 regulates astrocytic response following spinal cord injury. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2012;32(50):17935–47.
Jia P, Pan T, Xu S, Fang Y, Song N, Guo M, et al. Depletion of miR-21 in dendritic cells aggravates renal ischemia-reperfusion injury. FASEB J. 2020;34(9):11729–11740.
Lu M, Jiang X, Tong L, Zhang F, Ma L, Dong X, et al. MicroRNA-21-regulated activation of the Akt pathway participates in the protective effects of H2S against liver ischemia-reperfusion injury. Biol Pharm Bull. 2018;41(2):229–38.
Buscaglia LE, Li Y. Apoptosis and the target genes of microRNA-21. Chin J Cancer. 2011;30(6):371–80.
Yang F, Liu W, Yan X, Zhou H, Zhang H, Liu J, et al. Effects of mir-21 on cardiac microvascular endothelial cells after acute myocardial infarction in rats: role of phosphatase and tensin homolog (PTEN)/vascular endothelial growth factor (VEGF) signal pathway. Medical science monitor: international medical journal of experimental and clinical research. 2016;22:3562–75.
Yang C, Hawkins KE, Dore S, Candelario-Jalil E. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol. 2019;316(2):C135–53.
Yi JH, Park SW, Kapadia R, Vemuganti R. Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage. Neurochem Int. 2007;50(7–8):1014–27.
Sahni V, Mukhopadhyay A, Tysseling V, Hebert A, Birch D, McGuire TL, et al. BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injury. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2010;30(5):1839–55.
Ge X, Huang S, Gao H, Han Z, Chen F, Zhang S, et al. miR-21-5p alleviates leakage of injured brain microvascular endothelial barrier in vitro through suppressing inflammation and apoptosis. Brain Res. 2016;1650:31–40.
Redell JB, Zhao J, Dash PK. Altered expression of miRNA-21 and its targets in the hippocampus after traumatic brain injury. J Neurosci Res. 2011;89(2):212–21.
Sandhir R, Gregory E, Berman NE. Differential response of miRNA-21 and its targets after traumatic brain injury in aging mice. Neurochem Int. 2014;78:117–21.
Goellner EM, Putnam CD, Graham WJT, Rahal CM, Li BZ, Kolodner RD. Identification of Exo1-Msh2 interaction motifs in DNA mismatch repair and new Msh2-binding partners. Nat Struct Mol Biol. 2018;25(8):650–9.
Li L, Tao G, Hill MC, Zhang M, Morikawa Y, Martin JF. Pitx2 maintains mitochondrial function during regeneration to prevent myocardial fat deposition. Development. 2018;145(18):dev168609.
Kamath SP, Chen AI. Myocyte enhancer factor 2c regulates dendritic complexity and connectivity of cerebellar purkinje cells. Mol Neurobiol. 2019;56(6):4102–19.
Mitchell AC, Javidfar B, Pothula V, Ibi D, Shen EY, Peter CJ, et al. MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice. Mol Psychiatry. 2018;23(1):123–32.
Acknowledgements
This work was supported by Award 1I01-BX005127-01 from the U.S. Department of Veterans Affairs Biomedical Research Laboratory Research and Development Service of the VA Office of Research Development and the Dept. of Neurological Surgery, UW-Madison. MSL received a SciMedGRS/Centennial Graduate Student Scholarship.
Funding
This work was partially supported by Award 1I01-BX005127-01 from the U.S. Department of Veterans Affairs Biomedical Research Laboratory Research and Development Service of the VA Office of Research Development and the Dept. of Neurological Surgery, UW-Madison. Dr. Vemuganti is the recipient of a Research Career Scientist award (# IK6BX005690) from the US Department of Veterans Affairs. Mary Lopez received a SciMedGRS/Centennial Graduate Student Scholarship.
Author information
Authors and Affiliations
Contributions
MSL and KCM-B, NL, and CM conducted the experiments and analyzed the data. RV and RJD conceptualized the project. MSL and RV drafted the paper.
Corresponding author
Ethics declarations
Ethics Approval
All animal protocols were approved by the Research Animal Resources and Care Committee of the University of Wisconsin-Madison, and animals were cared for in accordance with the Guide for the Care and Use of Laboratory Animals (U.S. Department of Health and Human Services Publication 86–23, revised). Studies were conducted and reported in accordance to the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines.
Consent to Participate
This is an animal study, and hence, this section is not applicable.
Consent for Publication
Authors consent to the publication of this paper.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lopez, M.S., Morris-Blanco, K.C., Ly, N. et al. MicroRNA miR-21 Decreases Post-stroke Brain Damage in Rodents. Transl. Stroke Res. 13, 483–493 (2022). https://doi.org/10.1007/s12975-021-00952-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12975-021-00952-y